Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

September 30, 2015

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

capecitabine

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Trial Locations (25)

Unknown

Bank of Cyprus Oncology Centre, Nicosia

Royal United Hospital, Bath

Royal Bournemouth Hospital, Bournemouth

Addenbrookes Hospital, Cambridge

Darent Valley Hospital, Dartford

Hereford County Hospital, Hereford

Charing Cross Hospital, London

Guys and St Thomas' hospitals, London

Dorset Cancer Centre, Poole Hospital, Poole

Southport and Ormskirk, Southport

St Helens and Whiston hospitals, St Helens

Warrington and Halton Hospitals, Warrington

Worcestershire Royal Hospital, Worcester

BD9 6RJ

Bradford Royal Infirmary, Bradford

GL53 7AN

Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham

C03 3NB

Essex County Hospital, Colchester

DT1 2JY

Dorset County Hospital, Dorchester

GU2 7XX

St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford

W12 OHS

Hammersmith Hospital, London

W2 1NY

St. Mary's Hospital, London

OX3 7LJ

Churchill Hospital, Oxford

PE3 6DA

Peterborough Hospitals Trust, Peterborough

ST4 7LN

University Hospital of North Staffordshire, Stoke-on-Trent

SA2 8QA

Singleton Hospital, Swansea

S10 2SJ

Weston Park, Sheffield

All Listed Sponsors
lead

Cheryl Pugh

OTHER_GOV

NCT00640081 - Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter